A molecular approach for isolating high-affinity Fab fragments that are useful in blood group serology

Transfusion

Volumn 39, Issue 4, 1999, Pages 364-371

  Czerwinski, Marcin ^a   Krop Watorek, Anna ^d   Siegel, Don L ^b   Spitalnik, Steven ^c  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; GLYCOPHORIN A; IMMUNOGLOBULIN F(AB) FRAGMENT; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; BINDING AFFINITY; BLOOD GROUP SYSTEM; ENZYME LINKED IMMUNOSORBENT ASSAY; HYBRIDOMA; MALE; MOUSE; NONHUMAN;

EID: 0032926939     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1999.39499235667.x     Document Type: Article

References (39)

1. Chasis JA, Mohandas N. Red blood cell glycophorins. Blood 1992;80:1869-79.
2. Blumenfeld OO, Adamany AM. Structural polymorphism within the amino-terminal region of MM, NN, and MN glycoproteins (glycophorins) of the human erythrocyte membrane. Proc Natl Acad Sci U S A 1978;75:2727-31.
3. Wasniowska K, Drzeniek Z, Lisowska E. The amino acids of M and N blood group glycopeptides are different. Biochem Biophys Res Commun 1976;76:385-90.
4. Tomita M, Marchesi VT. Amino-acid sequence and oligosaccharide attachment sites of human erythrocyte glycophorin. Proc Natl Acad Sci U S A 1975;72:2964-8.
5. Lisowska E, Duk M, Dahr W. Comparison of the alkali-labile oligosaccharide chains of M and N blood group glycopeptides from human erythrocyte membrane. Carbohydr Res 1980;79:103-13.
6. Telischi M, Behzak O, Issitt PD, Pavone BG. Hemolytic disease of the newborn due to anti-N. Vox Sang 1976;31:109-16.
7. Jaskiewicz E, Moulds JJ, Kraemer K, et al. Characterization of the epitope recognized by a monoclonal antibody highly specific for blood group M antigen. Transfusion 1990;30:230-5.
8. Bigbee WL, Vanderlaan M, Fong SSN, Jensen RH. Monoclonal antibodies specific for the M and N forms of human glycophorin A. Mol Immunol 1983;20:1353-62.
9. v type chimpanzee erythrocytes. J Immunol 1984;133:3149-55.
10. Rubocki R, Milgrom F. Reactions of murine monoclonal antibodies to blood group MN antigens. Vox Sang 1986;51:217-25.
11. Wasniowska K, Duk M, Steuden I, et al. Two monoclonal antibodies recognizing different epitopes of blood group N antigen. Arch Immunol Ther Exp 1988;36:623-32.
12. Czerwinski M, Siegel DL, Moore JS, et al. Construction of bacteriophage expressing mouse monoclonal Fab fragments directed against the human MN glycophorin blood group antigens. Transfusion 1995;35:137-44.
13. Czerwinski M, Siemaszko D, Siegel DL, Spitalnik SL. Only selected light chains combine with a given heavy chain to confer specificity for a model glycopeptide antigen. J Immunol 1998;160:4406-17.
14. Kang AS, Jones TM, Burton DR. Antibody redesign by chain shuffling from random combinatorial immunoglobulin libraries. Proc Natl Acad Sci U S A 1991;88:11120-3.
15. Collet TA, Roben P, O'Kennedy R, et al. A binary plasmid system for shuffling combinatorial antibody libraries. Proc Natl Acad Sci U S A 1992;89:10026-30.
16. Lisowska E, Messeter L, Duk M, et al. A monoclonal antiglycophorin A antibody recognizing the blood group M determinant: studies on the subspecificity. Mol Immunol 1987;24:605-13.
17. Fraker PJ, Speck JC. Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycoluril. Biochem Biophys Res Commun 1978;80:849-57.
18. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
19. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5.
20. Barbas CF, Burton DR. Cold Spring Harbor Laboratory course on monoclonal antibodies from combinatorial libraries. Course materials. Cold Spring Harbor, NY: CSHL, 1994.
21. Czerwinski M, Blackall DP, Abrams WR, et al. Restricted VH gene usage by murine hybridomas directed against the human N, but not M, blood group antigen. Mol Immunol 1994;31:279-88.
22. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
23. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989.
24. Wojczyk BS, Czerwinski ME, Stwora-Wojczyk MM, et al. Purification of a secreted recombinant form of rabies virus glycoprotein: comparison of two affinity tags. Protein Exp Purif 1996;7:183-93.
25. Harrison JL, Williams SC, Winter G, Nissim A. Screening of phage antibody libraries. Methods Enzymol 1996;267:83-109.
26. Friguet B, Chaffotte AF, Djavadi-Ohaniance L, Goldberg ME. Measurements of the true affinity constant in solution of antigen-antibody complexes by enzyme-linked immunosorbent assay. J Immunol Methods 1985;77:305-19.
27. Blackall DP, Ugorski M, Pahlsson P, et al. A molecular biological approach to study the fine specificity of antibodies directed to the MN human blood group antigens. J Immunol 1994;152:2241-7.
28. Duk M, Sticher U, Brossmer R, Lisowska E. The differences in significance of 2,3Gal-linked and 2,6GalNAc-linked sialic acid residues in blood group M- and N-related epitopes recognized by various monoclonal antibodies. Glycobiology 1994;4:175-81.
29. Jaskiewicz E, Lisowska E, Lundblad A. The role of carbohydrate in the blood group N-related epitopes recognized by three new monoclonal antibodies. Glycoconjugate J 1990;7:225-68.
30. Abraham R, Buxbaum S, Link J, et al. Screening and knetic analysis of recombinant anti-CEA antibody fragments. J Immunol Methods 1995;183:119-25.
31. Yelton DE, Rosok MJ, Cruz G, et al. Affinity maturation of the BR96 anti-carcinoma antibody by codon-based mutagenesis. J Immunol 1995;155:1994-2004.
32. Ohlin M, Owman H, Mach M, Borrebaeck CA. Light chain shuffling of a high affinity antibody results in a drift in epitope recognition. Mol Immunol 1996;33:47-56.
33. Sharon J. Structural correlates of high antibody activity: three engineered amino acid substitutions can increase the affinity of an anti-p-azophenylarsonate antibody 200-fold. Proc Natl Acad Sci U S A 1990;87:4814-7.
34. Kussie PH, Parhami-Seren B, Wysocki LJ, Margolies MN. A single engineered amino acid substitution changes antibody fine specificity. J Immunol 1994;152:146-52.
35. Jackson JR, Sathe G, Rosenberg M, Sweet R. In vitro antibody maturation. Improvement of a high affinity, neutralizing antibody against IL-IbJ Immunol 1995;154:3310-9.
36. Glockshuber R, Stadlmuller I, Pluckthun A. Mapping and modification of an antibody hapten binding site: a site-directed mutagenesis study of McPC603. Biochemistry 1991;30:3049-54.
37. Denzin LK, Whitlow M, Voss EW. Single-chain site-specific mutations of fluorescein-amino acid contact residues in high affinity monoclonal antibody 4-4-20. J Biol Chem 1991;266:14095-103.
38. Schildbach JF, Near RI, Bruccoleri RE, et al. Heavy chain position 50 is a determinant of affinity and specificity for the anti-digoxin antibody 26-10. J Biol Chem 1993;268:21739-47.
39. Knappik A, Pluckthun A. An improved affinity tag based on the FLAG peptide for the detection and purification of recombinant antibody fragments. Biotechniques 1994;17:754-61.